Felix Kim

Dr. Felix Kim is Co-founder and Chair of the Scientific Advisory Board of Context Therapeutics. In addition, Felix is currently an Associate Professor of Cancer Biology at Sidney Kimmel Cancer Center at Thomas Jefferson University College of Medicine and is Chair of the Division of Translational Pharmacology of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Prior to receiving his faculty position at Jefferson, Felix was an Assistant Professor of Pharmacology at Drexel University College of Medicine. Felix completed a Post-Doctoral Fellowship with Dr. Gavril Pasternak at the Memorial Sloan Kettering Cancer Center. Felix is a leading authority on Sigma1 biology, having authored some of the seminal works in the field. He holds a Ph.D. in Biochemistry from Universitè Montepellier (France) and a B.S. in Biology from the University of California San Diego.